early experience program
Ferring launches bladder cancer gene therapy Adstiladrin in US through early experience program
Anika Sharma
Ferring Pharmaceuticals achieved a significant milestone by administering its groundbreaking gene therapy, Adstiladrin, to its first commercial patient. This innovative ...
